Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St Jude and Heartport receive investigational device exemption (IDE) for heart valve trial

This article was originally published in Clinica

Executive Summary

St Jude Medical and Heartport have received an IDE for trials of their minimally invasive heart valve repair and replacement system. The two US companies have been collaborating on the technique, which allows heart surgery to be performed through incisions between the ribs, for about 18 months and announced the joint development agreement in September 1995 (see Clinica No 672, p 1). The technique is expected to reduce hospital stay and recovery time for heart-surgery patients.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel